RECRUITING

Behavioral Intervention for Youth to Promote Vaping Cessation

Description

This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting support). Approximately 400 adolescents will be randomly assigned to one of two arms (1) QuitVaping intervention plus texting support to quit vaping and (2) EUC only.

Study Overview

Study Details

Study overview

This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting support). Approximately 400 adolescents will be randomly assigned to one of two arms (1) QuitVaping intervention plus texting support to quit vaping and (2) EUC only.

Behavioral Intervention for Youth to Promote Vaping Cessation

Behavioral Intervention for Youth to Promote Vaping Cessation

Condition
Vaping
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114, Boston, Massachusetts, United States, 02114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 14-18 inclusive
  • * Self-report of at least weekly nicotine vaping for the prior ≥3 months and semiquantitative saliva screening for cotinine positive for recent nicotine use
  • * Self-report of no regular combusted tobacco use (5 consecutive days of smoked tobacco use) in the 2 months prior to enrollment and exhaled CO \<10 ppm
  • * Report willingness to try to quit vaping in the next 30 days
  • * Able to understand study procedures and read and write in English or Spanish
  • * Have a parent or legal guardian who is able and willing to provide written informed consent (if under age 18)
  • * Competent and willing to provide written informed consent (if age 18) or assent (if under 18)
  • * Use of a smoking cessation medication in the prior month (nicotine patch, gum, nasal spray, or inhaler, varenicline, bupropion)
  • * Unwilling to abstain during the study from using smoking cessation aids other than those provided by the study
  • * Unwilling to provide saliva or urine samples
  • * Any condition or situation that would, in the investigator's opinion, make it unlikely that the participant could adhere safely to the study protocol

Ages Eligible for Study

14 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Massachusetts General Hospital,

A. Eden Evins, MD, MPH, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Randi M. Schuster, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2028-09-27